[HTML][HTML] Changes in neoadjuvant chemotherapy utilization in muscle invasive bladder cancer treatment: a tertiary center retrospective study

K Gronostaj, AK Czech, J Fronczek, T Wiatr… - … European Journal of …, 2020 - ncbi.nlm.nih.gov
… The aim of this study was to investigate temporal changes in neoadjuvant chemotherapy (NAC)
utilization in patients who underwent radical cystectomy (RC) due to muscle invasive …

Sociodemographic Disparities in Access to Chemotherapy for Bladder Cancer

S Venkat, PJ Lewicki, AI Khan, C Gaffney… - Clinical Genitourinary …, 2022 - Elsevier
… neoadjuvant chemotherapy (NAC) prior to cystectomy has … , with factors such as patient
refusal, need for immediate surgery, … Efforts must be made to understand this inequality further …

Failing to close the gap between evidence and clinical practice in radical bladder cancer radiotherapy

S Hafeez, R Lewis, C Griffin, E Hall… - Clinical …, 2021 - clinicaloncologyonline.net
… Radiotherapy was only reserved for patients deemed unfit for cystectomy. This meant …
for the use neoadjuvant chemotherapy and concurrent radiosensitisation remains low [ …

Conductive hyperthermic chemotherapy versus electromotive drug administration of mitomycin C as intravesical adjuvant treatment of patients with intermediate or …

MTM Segura, AM Martínez, YY Castillo… - … Oncology: Seminars and …, 2023 - Elsevier
… restaging TURBT, 1 patient refused to participate, and another was lost to follow-up … of
avoiding or delaying such disabling surgery as cystectomy [26]. In order to identify and understand

[HTML][HTML] Bladder cancer

H Kaseb, S Leslie, T Soon-Sutton, N Aeddula - StatPearls, 2024 - statpearls.com
… Intravesical chemotherapy or BCG can be considered in … who refused, could not tolerate, or
were ineligible for prior … to undergo radical cystectomy and who clearly understand the risks …

Position statement on the diagnosis and management of premature/primary ovarian insufficiency (except Turner Syndrome)

S Christin-Maitre, M Givony, F Albarel, A Bachelot… - Annales d' …, 2021 - Elsevier
… ) is to provide health professionals with an explanation of the state of the art in diagnosis …
, or be iatrogenic, following ovariectomy or bilateral cystectomy or chemotherapy (especially …

[HTML][HTML] Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer

EK Nguyen, H Yu, G Pond, B Shayegan… - Canadian Urological …, 2020 - ncbi.nlm.nih.gov
… An international phase 3 trial (BA06 30894) looked at patients receiving neoadjuvant
chemotherapy prior to radiotherapy or cystectomy and performed a subgroup analysis of the 403 …

Hard times: prostate cancer patients' experiences with erectile aids

LM Walker, CS Sears… - The journal of sexual …, 2021 - academic.oup.com
… providing insight into reasons for abandonment of use of EAs. … Participants who reported
receiving chemotherapy or using a … on the current understanding of EA use and discontinuation. …

[PDF][PDF] Steven D. Pearson, MD President Institute for Clinical and Economic Review Two Liberty Square, Ninth Floor Boston, MA 02109

DD Pearson - Cancer Nursing, 2020 - icer.org
… to more patients avoiding potentially curative cystectomy and … PIPC encourages ICER to
abandon the use of the QALY for … ineligible or refused to have a cystectomy. As a consequence, …

[PDF][PDF] Improved therapeutic strategies in non-muscle invasive bladder cancer

FJP van Valenberg - 2021 - repository.ubn.ru.nl
… sparing treatments as opposed to radical cystectomy is a … all, whereas two patients refused
to undergo the second dosing … We hypothesized that this observation might be explained by …